From Genetics to Lived Experience: Reflections on our Sickle Cell Awareness Month Series

Throughout Sickle Cell Awareness Month, we explored sickle cell disease through the lens of genomic medicine, lived experience and holistic care.

Across our five-part LinkedIn series, we shared expert insights, personal stories and emerging developments in treatment to help improve understanding of the UK’s most common inherited blood disorder.

While each story offered a different perspective, together they highlighted an important message: improving outcomes for people living with sickle cell disease requires more than medical treatment alone. It requires innovation, compassionate care and listening to the experiences of those living with the condition.

Understanding sickle cell disease

We began by exploring the genetic basis of sickle cell disease and the important role genomics plays in diagnosis, carrier identification, family planning and the development of new treatments.

Around 19,000 people are living with sickle cell disease in the UK, with approximately 300 babies born with the condition each year.

The reality behind the diagnosis

On Day 2, we shared Brenda’s story. Despite experiencing symptoms throughout childhood, she was not diagnosed until the age of ten and later faced delays accessing care after moving to the UK.

Her experiences highlighted some of the challenges people living with sickle cell disease can still face, including stigma, unequal experiences of care and a lack of awareness about the condition. Today, Brenda uses her lived experience to advocate for greater understanding and improved services.

How genomics is shaping the future of care

As our understanding of the genetics behind sickle cell disease grows, so too does the potential for new treatments.

Current care focuses on managing symptoms and preventing complications, but advances in genomic medicine are creating opportunities to target the underlying cause of the condition. In our Day 3 feature, we explored how emerging gene editing therapies could transform the future of care for people living with inherited conditions.

Continuing the conversation

Thank you to everyone who followed our Sickle Cell Awareness Month series.

As genomic medicine continues to advance, it is important that we continue to raise awareness, challenge misconceptions and place the experiences of patients at the centre of care. By combining scientific innovation with compassionate, personalised care, we can help create a better future for people living with sickle cell disease.

Catch up on the series:

Brenda’s Story: Living with Sickle Cell Disease
Why Nutrition Must Be a Part of Personalised Sickle Cell Care